Similar trend as depicted in Figure 4B, showed lower expression of cytoplasmic EGFR in RCC patients had a poorer survival outcome compared with those with higher expression of cytoplasmic EGFR. The gene discussed is EGFR; the disease is renal cell adenocarcinoma.